INFI News and Press, Infinity Pharmaceuticals Inc. From 01/09/20

-- Fully funds all ongoing IPI-549 clinical trials through key data readouts -- -- Non-dilutive financing extends cash runway into 2H 2021 -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) (“Infinity”) today announced a $20 million non-dilutive asset-backed financing ...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today that Adelene Perkins, Chief Executive Officer and Chair of Infinity Pharmaceuticals, will provide a corporate overview at the 38 th Annual J.P. Morgan Global Healthcare Conference on Thursday, January 16, 2020 at 9:00 am Pacific T...

Acasti Pharma (NASDAQ: ACST ) resume with Buy rating and $8 (292% upside) price target at B. Riley FBR. Shares up  5%  premarket. More news on: Acasti Pharma Inc., Champions Oncology, Inc., DexCom, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Announced that positive results from its previously announced phase 1b REO 024 study of pelareorep in combination with pembrolizumab (Merck's Keytruda®) have been published in the peer-reviewed medical journal Clinical Cancer Research, a journal of the American Association for Cancer Rese...

Within a global market that’s projected to grow at a rate of 12.3% CAGR to hit US$196.2 billion by 2026 , there are several encouraging improvements on the way in the oncology drug market, thanks to new pairings and studies. Among the current developments are innovations coming from d...

Infinity Pharmaceuticals, Inc. (INFI) Q3 2019 Earnings Conference Call October 30, 2019 04:30 PM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Lawrence Bloch - President Jeff Kutok - Chief Scientific Officer Conference Call Parti...

Infinity Pharmaceuticals (NASDAQ: INFI ): Q3 GAAP EPS of -$0.20 misses by $0.01 . More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...

-- MARIO-1 Enrollment Completion Expected in 2019 and Data Presentation Expected in 2020 -- -- MARIO-3 Enrollment Completion and Data Presentation Expected in 2020 -- -- MARIO-275 Enrollment Completion Expected in 2020 -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today ...

October 30, 2019 FN Media Group Presents USA News Group Commentary Los Angeles, CA – October 30, 2019 – USA News Group – As October rolled in to welcome the 35 th annual Breast Cancer Awareness Month , hope remains alive as new drugs continue to develop...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Wednesday, October 30, 2019 at 4:30 p.m. ET to review its third quarter 2019 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Investors/Media se...